Looking for a potential run-up heading into the PDUFA announcement on 30-Dec.
Reasoning:
Ex-CEO David Dodd left the company just before a lawsuit was launched against him for trying to obtain personal rights for the lead drug candidate Macrilen. For him to act in such a way, its quite possible that he see good future potential for the product.
Buy zone: $1.60 - $1.80
Profit zone: $2.60 or higher
Stop zone: $1.40 or lower
Reasoning:
Ex-CEO David Dodd left the company just before a lawsuit was launched against him for trying to obtain personal rights for the lead drug candidate Macrilen. For him to act in such a way, its quite possible that he see good future potential for the product.
Buy zone: $1.60 - $1.80
Profit zone: $2.60 or higher
Stop zone: $1.40 or lower